Werner Neidhart

3.1k total citations · 2 hit papers
30 papers, 2.2k citations indexed

About

Werner Neidhart is a scholar working on Molecular Biology, Computational Theory and Mathematics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Werner Neidhart has authored 30 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Computational Theory and Mathematics and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Werner Neidhart's work include Chemical Synthesis and Analysis (9 papers), Computational Drug Discovery Methods (9 papers) and Receptor Mechanisms and Signaling (8 papers). Werner Neidhart is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Computational Drug Discovery Methods (9 papers) and Receptor Mechanisms and Signaling (8 papers). Werner Neidhart collaborates with scholars based in Switzerland, Germany and United States. Werner Neidhart's co-authors include Gisbert Schneider, Thomas Giller, Gerard M. Schmid, Volker Breu, Martine Clozel, Kaspar F. Burri, Georges Hirth, Gillian A. Gray, Jean‐Marie Cassal and Henri Ramuz and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Werner Neidhart

30 papers receiving 2.1k citations

Hit Papers

Pharmacological characterization of bosentan, a new poten... 1994 2026 2004 2015 1994 1999 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
    1994 590 citations Martine Clozel, Volker Breu et al. Journal of Pharmacology and Experimental Therapeutics profile →
  2. “Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening
    1999 543 citations Gisbert Schneider, Werner Neidhart et al. Angewandte Chemie International Edition profile →

Peers

Werner Neidhart
Stephen J. Gardell United States
Thomas Giller Switzerland
Alexander Straub Germany
Thomas P. Kasten United States
Michael R. Jirousek United States
Paula M. Loria United States
Jenny Chong United States
David Aharony United States
Liming Hou China
C. Hirth France
Stephen J. Gardell United States
Werner Neidhart
Citations per year, relative to Werner Neidhart Werner Neidhart (= 1×) peers Stephen J. Gardell

Countries citing papers authored by Werner Neidhart

Since Specialization
Citations

This map shows the geographic impact of Werner Neidhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Neidhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Neidhart more than expected).

Fields of papers citing papers by Werner Neidhart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Neidhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Neidhart. The network helps show where Werner Neidhart may publish in the future.

Co-authorship network of co-authors of Werner Neidhart

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Neidhart. A scholar is included among the top collaborators of Werner Neidhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Neidhart. Werner Neidhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bissantz, Caterina, Johan Bylund, Anja Limberg, et al.. (2020). Stepwise Design of γ-Secretase Modulators with an Advanced Profile by Judicious Coordinated Structural Replacements and an Unconventional Phenyl Ring Bioisostere. Journal of Medicinal Chemistry. 63(15). 8534–8553. 17 indexed citations
2.
Obst-Sander, U., Bernd Kuhn, Simona Ceccarelli, et al.. (2016). Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(20). 5092–5097. 19 indexed citations
3.
Kuhn, Bernd, Wolfgang Guba, Jérôme Hert, et al.. (2016). A Real-World Perspective on Molecular Design. Journal of Medicinal Chemistry. 59(9). 4087–4102. 80 indexed citations
4.
Neidhart, Werner, Tanja Schulz‐Gasch, A. Ruf, et al.. (2015). Challenges and Rewards in Medicinal Chemistry Targeting Cardiovascular and Metabolic Diseases. CHIMIA International Journal for Chemistry. 69(7-8). 407–407. 1 indexed citations
5.
Dutzler, Raimund, Beat Ernst, Matthias A. Hediger, et al.. (2010). Channels and Transporters. CHIMIA International Journal for Chemistry. 64(9). 662–662. 5 indexed citations
6.
Neidhart, Werner, Hans Peter Märki, & Peter Möhr. (2009). Frontiers in Medicinal Chemistry – Joint German-Swiss Meeting on Medicinal Chemistry: Heidelberg, Germany, March 15–18, 2009. CHIMIA International Journal for Chemistry. 63(9). 573–573. 1 indexed citations
7.
Nettekoven, Matthias, Wolfgang Guba, Werner Neidhart, et al.. (2005). Aminothiazole Derivatives as Neuropeptide Y5 Receptor Ligands: Finding the Balance between Affinity and Physicochemical Properties. ChemMedChem. 1(1). 45–48. 10 indexed citations
8.
Guba, Wolfgang, Werner Neidhart, & Matthias Nettekoven. (2005). Novel and potent NPY5 receptor antagonists derived from virtual screening and iterative parallel chemistry design. Bioorganic & Medicinal Chemistry Letters. 15(6). 1599–1603. 25 indexed citations
9.
Dautzenberg, Frank M., Jacqueline Higelin, Philippe Pflieger, Werner Neidhart, & Wolfgang Guba. (2005). Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist. Neuropharmacology. 48(7). 1043–1055. 12 indexed citations
10.
Nettekoven, Matthias, Wolfgang Guba, Werner Neidhart, et al.. (2005). Isomeric thiazole derivatives as ligands for the neuropeptide Y5 receptor. Bioorganic & Medicinal Chemistry Letters. 15(14). 3446–3449. 10 indexed citations
11.
Schneider, Gisbert, Odile Clément‐Chomienne, Petra Schneider, et al.. (2000). Virtual Screening for Bioactive Molecules by Evolutionary De Novo Design. Angewandte Chemie International Edition. 39(22). 4130–4133. 5 indexed citations
12.
Schneider, Gisbert, Odile Clément‐Chomienne, Petra Schneider, et al.. (2000). Virtual Screening for Bioactive Molecules by Evolutionary De Novo Design. Angewandte Chemie International Edition. 39(22). 4130–4133. 53 indexed citations
13.
Schneider, Gisbert, Odile Clément‐Chomienne, Petra Schneider, et al.. (2000). Evolutionäres De-novo-Design bioaktiver Moleküle: ein Ansatz zum virtuellen Screening. Angewandte Chemie. 112(22). 4305–4309. 3 indexed citations
14.
Schneider, Gisbert, Werner Neidhart, Thomas Giller, & Gerard M. Schmid. (1999). „Grundgerüstwechsel” (Scaffold-Hopping) durch topologische Pharmakophorsuche: ein Beitrag zum virtuellen Screening. Angewandte Chemie. 111(19). 3068–3070. 46 indexed citations
15.
Schneider, Gisbert, Werner Neidhart, Thomas Giller, & Gerard M. Schmid. (1999). “Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening. Angewandte Chemie International Edition. 38(19). 2894–2896. 12 indexed citations
16.
Roux, Sébastiên, Volker Breu, Thomas Giller, et al.. (1997). Ro 61–1790, a New Hydrosoluble Endothelin Antagonist: General Pharmacology and Effects on Experimental Cerebral Vasospasm. Journal of Pharmacology and Experimental Therapeutics. 283(3). 1110–1118. 86 indexed citations
17.
Breu, Volker, Martine Clozel, Kaspar F. Burri, et al.. (1996). In vitro characterisation of Ro 46‐8443, the first non‐peptide antagonist selective for the endothelin ETB receptor. FEBS Letters. 383(1-2). 37–41. 31 indexed citations
18.
Clozel, Martine, Volker Breu, Gillian A. Gray, et al.. (1994). Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.. Journal of Pharmacology and Experimental Therapeutics. 270(1). 228–235. 590 indexed citations breakdown →
19.
Clozel, Martine, Volker Breu, Kaspar F. Burri, et al.. (1993). Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 365(6448). 759–761. 426 indexed citations
20.
Fischli, Walter, et al.. (1991). Ro 42-5892 is a potent orally active renin inhibitor in primates.. Hypertension. 18(1). 22–31. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen J. Gardell Breakdown of academic impact, for papers by Thomas Giller Breakdown of academic impact, for papers by Alexander Straub Breakdown of academic impact, for papers by Thomas P. Kasten Breakdown of academic impact, for papers by Michael R. Jirousek Breakdown of academic impact, for papers by Paula M. Loria Breakdown of academic impact, for papers by Jenny Chong Breakdown of academic impact, for papers by David Aharony Breakdown of academic impact, for papers by Liming Hou Breakdown of academic impact, for papers by C. Hirth
Rankless by CCL
2026